Biotech & Bioprocessing

How Does circMAN1A2-CENPB Interaction Drive Cancer Growth?
Biotech & Bioprocessing How Does circMAN1A2-CENPB Interaction Drive Cancer Growth?

Cancer research has taken a remarkable leap forward with a recent study published in Nature Communications by Cao et al., shedding light on a previously unknown molecular mechanism that fuels tumor growth and opens new avenues for therapy. This groundbreaking work reveals a unique interaction

Comparing Influenza A Virus in 2D and 3D Cell Cultures
Biotech & Bioprocessing Comparing Influenza A Virus in 2D and 3D Cell Cultures

In the realm of virology, understanding how viruses interact with host cells is paramount to developing effective treatments and preventive measures, particularly for respiratory pathogens like the influenza A virus, which poses significant public health challenges. Traditional two-dimensional (2D)

Innovation Reshapes Pharma at DCAT Summit Lugano 2025
Biotech & Bioprocessing Innovation Reshapes Pharma at DCAT Summit Lugano 2025

The pharmaceutical industry stands at a critical juncture, where the urgent need for faster, more sustainable, and patient-focused solutions is driving unprecedented change, as vividly demonstrated at the DCAT Summit held on June 4–5 in Lugano, Switzerland. Under the compelling theme "Expedition

Fungi-Inspired Hydrogels Revolutionize Biomedical Materials
Biotech & Bioprocessing Fungi-Inspired Hydrogels Revolutionize Biomedical Materials

Imagine a future where medical materials not only mimic the softness and resilience of human tissue but also heal themselves, all while being sourced directly from nature’s blueprint. At the University of Utah, a groundbreaking discovery has brought this vision closer to reality through

How Is Amgen Boosting US Biopharma with $650M in Puerto Rico?
Biotech & Bioprocessing How Is Amgen Boosting US Biopharma with $650M in Puerto Rico?

In a striking move that underscores the growing emphasis on domestic manufacturing in the biopharmaceutical sector, Amgen, a titan in the American biotech landscape, has committed a substantial $650 million to expand its biologics facility in Juncos, Puerto Rico. This investment is not merely a

FDA Clears AD-NP1 for Heart Failure Clinical Trials
Biotech & Bioprocessing FDA Clears AD-NP1 for Heart Failure Clinical Trials

Heart failure remains a formidable challenge in modern medicine, affecting millions globally and often leading to a diminished quality of life due to the heart's inability to pump blood effectively after injury. A groundbreaking development has emerged with the U.S. Food and Drug Administration

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later